SCN1B intron 3 retention results in a nonsense-mediated decay–sensitive mRNA linked to developmental and epileptic encephalopathy
Year: 2026
Type: article
Abstract: Biallelic variants in the voltage-gated sodium channel (VGSC) gene SCN1B are linked to developmental and epileptic encephalopathy type 52 (DEE52). SCN1B encodes two isoforms: transmembrane β1, generated by all 6 coding exons, and β1B, generated by exons 1 to 3 followed by retention of intron 3 ( SCN1B -IR). Transmembrane β1 subunits are multifunctional proteins that regulate sodium current and channel cell-surface expression, participate in cell–cell and cell–matrix adhesion, and modulate transcription. Several DEE52 variants in the transmembrane β1 coding region have been shown to result in mixed loss-of-function. DEE52 variants are also identified in SCN1B -IR, yet their functional impacts remain unknown. Here, we provide evidence that SCN1B -IR is a cell type–specific, nonsense-mediated decay (NMD)–sensitive transcript. We investigate a severe biallelic DEE52 patient variant in intron 3, SCN1B c.449-2A>G, which results in expression of SCN1B -IR, but not transmembrane β1 transcripts. A transgenic mouse model that expresses SCN1B -IR, but not transmembrane β1, transcript phenocopies Scn1b null mice with seizures and early death. Thus, SCN1B -IR functions as an NMD-sensitive transcript that cannot compensate for the loss of transmembrane β1. We propose that future work may reveal SCN1B -IR to be a therapeutic target similar to other NMD-targeted transcripts.
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W7235144630
